Vy Phan

ORCID: 0000-0002-8654-1013 · 5 papers in corpus
article 2026
Botulinum toxin for endometriosis-associated chronic pelvic pain: a randomised, double-masked, parallel, phase 2 trial
EClinicalMedicine ·doi:10.1016/j.eclinm.2025.103740

BACKGROUND: Chronic pelvic pain affects one in four women. Botulinum toxin, approved for chronic migraine and cervical dystonia pain, is an emerging treatment for other pain conditions. We evaluated intramuscular pelvic floor botulinum toxi…

article 2024
Changes in Pain Sensitization During a Clinical Trial of OnabotulinumtoxinA for Endometriosis-Associated Chronic Pelvic Pain
·doi:10.1016/j.toxicon.2024.107418
article 2021
RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BOTULINUM TOXIN FOR ENDOMETRIOSIS-RELATED CHRONIC PELVIC PAIN
·doi:10.1016/j.fertnstert.2021.07.148
article 2020
Widespread myofascial dysfunction and sensitisation in women with endometriosis‐associated chronic pelvic pain: A cross‐sectional study
European journal of pain (London, England) ·doi:10.1002/ejp.1713

BACKGROUND: Chronic pelvic pain persists in some women with endometriosis even after lesion removal and optimized hormonal treatment. OBJECTIVE: Characterize the presence and distribution of pain, myofascial dysfunction and sensitisation be…

article 2019
Pelvic floor muscle spasm, comorbid pain and mental health conditions in women with endometriosis-associated chronic pelvic pain
·doi:10.1016/j.fertnstert.2019.07.938